Stephen B. Thompson
Plus aucun poste en cours
Provenance du réseau au premier degré de Stephen B. Thompson
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 42 | |
OKC LP
1
| Extinct | Real Estate Development | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Stephen B. Thompson via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| LADRX CORPORATION | Biotechnology | Director/Board Member Chairman | |
MacroChem Corp.
 MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
| WINDTREE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Medical/Nursing Services | Director of Finance/CFO Director/Board Member | |
SCO Capital Partners LLC
 SCO Capital Partners LLC Investment ManagersFinance Founded in 1997, SCO Capital Partners LLC is a venture capital firm located in New York City. The firm is a subsidiary of SCO Financial Group LLC. | Investment Managers | Private Equity Investor Chief Investment Officer Private Equity Analyst Private Equity Investor | |
| GI DYNAMICS, INC. | Medical Specialties | Chief Executive Officer | |
Navitas Pharma, Inc.
 Navitas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Navitas Pharma, Inc. operates as a pharmaceutical company. The company is headquartered in Green River, WY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Southern Methodist University is a private university near the center of Dallas, SMU offers undergraduate, graduate, and professional programs through seven schools in the humanities and sciences, business, the performing, visual, and communication arts, engineering, education and human development, law, and theology. | College/University | Corporate Officer/Principal | |
| University of Virginia | College/University | Undergraduate Degree Masters Business Admin | |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Allen & Caron, Inc.
 Allen & Caron, Inc. Miscellaneous Commercial ServicesCommercial Services Allen & Caron, Inc. provides investor and media relations services primarily to small and mid-sized businesses. The company was founded by Joseph Allen in 1981 and is headquartered in Irvine, CA. | Miscellaneous Commercial Services | Public Communications Contact | |
| University of London | College/University | Doctorate Degree Masters Business Admin | |
| Georgetown University | College/University | Graduate Degree Undergraduate Degree | |
AMGEN GmbH
 AMGEN GmbH BiotechnologyHealth Technology AMGEN GmbH develops, manufactures, and markets human therapeutics based on cellular biology. It was established to help sell and distribute biotechnical therapies for the treatment of such ailments as chemotherapy side effects, chronic kidney failure, and rheumatoid arthritis. Among the group's products are Epogen & Aranesp for the treatment of anemia in people with chronic kidney disease; Neupogen & Neulasta to help restore white blood cell counts for cancer patients and Enbrel for the treatment of psoriasis and rheumatoid arthritis. The company was founded in 1980 and is headquartered in Munich, Germany. | Biotechnology | Chief Executive Officer | |
| University of Navarra | College/University | Doctorate Degree | |
| Universidad de Buenos Aires | College/University | Doctorate Degree | |
| Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree | |
| ULURU INC. | Medical Specialties | Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Philipps University of Marburg | College/University | Graduate Degree | |
Materials Research Society
 Materials Research Society Miscellaneous Commercial ServicesCommercial Services The Materials Research Society is an international, interdisciplinary science community that offers materials science journals, meetings, and outreach. Founded in 1973, the society is headquartered in Warrendale, PA and has over 11,200 members from more than 90 countries around the world. The society includes people from both developed and developing nations and has subcommittees for early career, student, and university chapters. The society explores the connections between the discovery of new materials and the development of technologies and social structures worldwide. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Controlled Release Society
 The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services The Controlled Release Society is a private company that focuses on providing fundamental delivery research, development, regulatory science, and clinical translation. The company is based in St. Paul, MN. The company was founded by Agis Kydonieus. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| FNAB | Chief Tech/Sci/R&D Officer | ||
OncoEthix SA
 OncoEthix SA Pharmaceuticals: MajorHealth Technology OncoEthix SA operates as a clinical stage biotechnology company which develops cancer drugs. Its products include OTX008, OTX015, and OTX009. The company was founded by Esteban Cvitkovic, Jeanne Kay Noel, Yves Paternot, and Patrice Herait in March 2007 and is headquartered in Luzern, Switzerland. | Pharmaceuticals: Major | Founder | |
Feinstein Kean Healthcare
 Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Feinstein Kean Healthcare is a private company that provides strategic communications consulting services. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Public Communications Contact | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Founder Human Resources Officer | |
| Contract Research Organization | Founder | ||
| SMU-Cox School of Business | College/University | Undergraduate Degree | |
| Instituto de Estudios Superiores de la Empresa | College/University | Masters Business Admin | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
OTD Oncology Therapeutic Development SARL
 OTD Oncology Therapeutic Development SARL Miscellaneous Commercial ServicesCommercial Services OTD Oncology Therapeutic Development SARL operates as a research and experimental development company in other physical and natural sciences. The company was founded by Esteban Cvitkovic in 2005 and is headquartered in Clichy, France. | Miscellaneous Commercial Services | Founder | |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Chief Executive Officer | |
PainQx, Inc.
 PainQx, Inc. Packaged SoftwareTechnology Services PainQx, Inc. develops healthcare software on a pay-per-use or subscription basis for both human health and veterinary applications. The firm develops the PainQx System, a software that generates pain analysis. The company was founded in 2015 by Frank Minella and Leslie S. Prichep and is headquartered in Kennett Square, PA. | Packaged Software | Director/Board Member | |
| Hudson Square Capital LLC | President | ||
| DESIGN THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Chairman Director of Finance/CFO | |
| Bridge Back Foundation | Chief Executive Officer | ||
Varian Biopharmaceuticals, Inc.
 Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Part of Healthtech Solutions, Inc., Varian Biopharmaceuticals, Inc. is a private precision oncology company based in Naples, FL. Varian Bio is developing novel therapeutics for the treatment of cancer using precision oncology, which involves DNA testing to identify genetic mutations in tumors for more targeted treatment recommendations. Varian Bio's lead drug candidate, Var-101, is being developed in a topical formulation for the treatment of basal cell carcinoma, while Var-102, an oral formulation, is being developed for the treatment of various solid tumors, including non-small cell lung cancer, pancreatic cancer, and colorectal cancer. Varian Bio is also seeking additional precision oncology therapeutic candidates for its pipeline and exploring development collaborations. The CEO of the company is Jeffrey Blaine Davis. Varian Biopharmaceuticals was acquired by Healthtech Solutions, Inc. on May 07, 2021. | Biotechnology | Chief Executive Officer Director/Board Member | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Comptroller/Controller/Auditor Chief Operating Officer Human Resources Officer | |
| American Professional Woundcare Association | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 37 |
| Royaume-Uni | 4 |
| Allemagne | 4 |
| Espagne | 4 |
| France | 4 |
Sectorielle
| Health Technology | 20 |
| Consumer Services | 13 |
| Commercial Services | 8 |
| Finance | 4 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 106 |
| Corporate Officer/Principal | 90 |
| President | 40 |
| Chief Executive Officer | 34 |
| Chairman | 31 |
Relations les plus connectées
| Insiders | |
|---|---|
| Max E. Link | 28 |
| Rosemary Mazanet | 24 |
| Mark J. Ahn | 20 |
| Jeffrey Davis | 17 |
| Stephen B. Howell | 16 |
| Todd Wider | 15 |
| Joao Siffert | 14 |
| Mark Alvino | 13 |
| David Luci | 13 |
| Glynn Wilson | 13 |
| Scott Schorer | 11 |
| Stefano Buono | 10 |
| Christine Silverstein | 10 |
| Steve H. Rouhandeh | 10 |
| Neena Patil | 9 |
- Bourse
- Insiders
- Stephen B. Thompson
- Connexions Sociétés
